News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Daily News TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps Yael L. Maxwell June 11, 2019
News Conference News SCAI 2019 ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3 Yael L. Maxwell June 05, 2019
News Daily News HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR L.A. McKeown March 13, 2019